1. Carnevale, Julia, Shifrut, Eric, Kale, Nupura, Ashworth, Alan, Marson, Alexander. 2022. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. In Nature, 609, 174-182. doi:10.1038/s41586-022-05126-w. https://pubmed.ncbi.nlm.nih.gov/36002574/
2. Zhu, Zheng, Teng, Zhimei, van Duijnhoven, Fränzel J B, Kampman, Ellen, Wu, Ming. 2017. Interactions between RASA2, CADM1, HIF1AN gene polymorphisms and body fatness with breast cancer: a population-based case-control study in China. In Oncotarget, 8, 98258-98269. doi:10.18632/oncotarget.21530. https://pubmed.ncbi.nlm.nih.gov/29228687/
3. Aoki, Yoko, Niihori, Tetsuya, Inoue, Shin-ichi, Matsubara, Yoichi. 2015. Recent advances in RASopathies. In Journal of human genetics, 61, 33-9. doi:10.1038/jhg.2015.114. https://pubmed.ncbi.nlm.nih.gov/26446362/
4. Arafeh, Rand, Qutob, Nouar, Emmanuel, Rafi, Hayward, Nicholas K, Samuels, Yardena. 2015. Recurrent inactivating RASA2 mutations in melanoma. In Nature genetics, 47, 1408-10. doi:10.1038/ng.3427. https://pubmed.ncbi.nlm.nih.gov/26502337/
5. Tidyman, William E, Rauen, Katherine A. 2016. Expansion of the RASopathies. In Current genetic medicine reports, 4, 57-64. doi:. https://pubmed.ncbi.nlm.nih.gov/27942422/
智鼠故事 
